Home > Insider Trading > Filing (0001209191-16-149491)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594864	Juno Therapeutics Inc.	JUNO	Biological Products, (No Disgnostic Substances) (2836)	463656275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1656998	Robert Azelby	C/O 307 Westlake Avenue N Ste 300 Seattle WA 98109	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-08	10,000	$0.00	48,640	No	4	A	Direct
Common Stock	Disposition	2016-11-10	12,921	$24.14	35,719	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2016-11-08	40,000	$0.00	40,000	$25.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,000		2026-11-07	No	4	A	Direct

Footnotes

Represents restricted stock units ("RSUs") granted pursuant to the 2014 Equity Incentive Plan. 25% of the RSUs vest on each anniversary of November 8, 2016.
The sale reported on this Form 4 was effected pursuant to an Issuer approved Rule 10b5-1 compliant sell-to-cover award, in order to cover tax withholding incident to the vesting of 38,640 RSUs. The number of shares sold to cover such withholding obligations was determined based on the trade price, which is equal to the average of the high and low prices of the Issuer's common stock on November 2, 2016, the next trading day following the date on which the RSUs vested.
1/48th of the shares subject to the option become vested and exercisable on December 8, 2016 and 1/48th of the shares subject to the option shall vest monthly thereafter.